Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint

Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Urology Unpaywall
Loading next page...
 
/lp/unpaywall/cabozantinib-versus-mitoxantrone-prednisone-in-symptomatic-metastatic-JiDj0qvWKV

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Unpaywall
ISSN
0302-2838
DOI
10.1016/j.eururo.2018.11.033
Publisher site
See Article on Publisher Site

Abstract

Journal

European UrologyUnpaywall

Published: Jun 1, 2019

There are no references for this article.